STAT3 and colonic neoplasm: Meanwhile, miR-1299 was found to be a negative regulator of ST AT3 in colon cancer [61], which targeted deletion of miR-139-5p, activating STAT3 signaling and promoting progression of colorectal cancer [62], and miR-125b inhibited cell proliferation by targeting STAT3 [63].